Inhibitory effect of harmine derivative B-9-3 combined with five traditional anti-tumor drugs on cancer cells in vitro

Qin MA,Wei CHEN,Wen CHEN
DOI: https://doi.org/10.7501/j.issn.1674-6376.2018.01.010
2018-01-01
Abstract:Objective To investigate the inhibitory effect of B-9-3 combined with five anti-cancer drugs on different tumor cells.Methods LLC,HT-29,HepG2,and MCF-7 cells were treated with B-9-3 (0.78~200.00 μg/mL) and Vimcristine,Taxol,5-fluorouracil,Cisplatin and Epirubicin in single-group or in combination for 48 h separately.The inhibitory effect on growth of tumor cells was determined by MTT assay,and the combination index (Q) was calculated according to WEBB method.In addition,the apoptosis rate and migration of LLC cells after 24 h treatment of B-9-3 in different consetration (0.78、25.00 和 200.00μg/mL)were determined by Pl/Hoechst33342 fluorescence staining and cell scratch test.Results Compared with B-9-3 alone group,B-9-3 in the same concentration combined with vincristine and paclitaxel reduced the survival rate of MCF-7 and HT-29 cells significantly,and Q was less than 0.3 (Q <1 for synergy).The results of fluorescence staining and cell scratch test showed that,compared with the solvent control group,the apoptosis rate of B-9-3 (25 and 200 g/mL) group increased significantly,and the rate of scratch repairing decreased significantly (P <0.01).Conclusion B-9-3 inhibits the migration of LLC cells and increases the rate of apoptosis significantly,and has synergistic effect with the combination of different antitumor drugs.
What problem does this paper attempt to address?